Search alternatives:
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
181
The trends of gene expression in the metabolism of triglycerides in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
182
After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
183
The trends of cholesterol metabolism-related gene expression in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
184
<sup>1</sup>H NMR spectra for kylo-0603.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
185
-
186
The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
187
The trends in the expression of inflammation-related genes in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
188
The Fibrosis scoring by Sirius Red staining and SHG/TPEF.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
189
Effects of Kylo-0603 on body weight, organ weight, and body fat content.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
190
The trends in the expression of fibrosis-related genes in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
191
Effects of Kylo-0603 on the expression of related genes of the MASH mouse models.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
192
-
193
<sup>13</sup>C NMR spectra for Kylo-0603.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
194
General procedure for the synthesis of A and A-c1.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
195
Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603...
Published 2025Subjects: “…attenuates fibrosis progression…”
-
196
-
197
Trends of peroxisome-related gene expression in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
198
NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day).
Published 2025Subjects: “…attenuates fibrosis progression…”
-
199
The body weight and cholesterol levels of the mice were recorded before the administration of the drug.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
200
Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine...
Published 2025Subjects: “…attenuates fibrosis progression…”